nodes	percent_of_prediction	percent_of_DWPC	metapath
Vinblastine—JUN—psoriasis	0.519	1	CbGaD
Vinblastine—ABCB11—Cyclosporine—psoriasis	0.0359	0.118	CbGbCtD
Vinblastine—ABCC1—Cyclosporine—psoriasis	0.0255	0.0841	CbGbCtD
Vinblastine—ABCC2—Mycophenolate mofetil—psoriasis	0.0249	0.0822	CbGbCtD
Vinblastine—ABCB11—Dexamethasone—psoriasis	0.0237	0.078	CbGbCtD
Vinblastine—ABCC2—Cyclosporine—psoriasis	0.0189	0.0623	CbGbCtD
Vinblastine—CYP2D6—Hydroxyurea—psoriasis	0.0146	0.0481	CbGbCtD
Vinblastine—ABCC1—Methotrexate—psoriasis	0.0135	0.0445	CbGbCtD
Vinblastine—ABCC2—Dexamethasone—psoriasis	0.0124	0.041	CbGbCtD
Vinblastine—CYP3A4—Calcitriol—psoriasis	0.0109	0.0359	CbGbCtD
Vinblastine—ABCC2—Methotrexate—psoriasis	0.01	0.033	CbGbCtD
Vinblastine—CYP2D6—Cholecalciferol—psoriasis	0.00883	0.0291	CbGbCtD
Vinblastine—ABCC6—dermis—psoriasis	0.0085	0.269	CbGeAlD
Vinblastine—CYP3A4—Methoxsalen—psoriasis	0.00848	0.0279	CbGbCtD
Vinblastine—ABCB1—Mycophenolate mofetil—psoriasis	0.00813	0.0268	CbGbCtD
Vinblastine—ABCB1—Betamethasone—psoriasis	0.00697	0.023	CbGbCtD
Vinblastine—ABCB1—Prednisolone—psoriasis	0.00688	0.0227	CbGbCtD
Vinblastine—ABCB1—Hydrocortisone—psoriasis	0.00652	0.0215	CbGbCtD
Vinblastine—ABCB1—Prednisone—psoriasis	0.0065	0.0214	CbGbCtD
Vinblastine—ABCB1—Cyclosporine—psoriasis	0.00616	0.0203	CbGbCtD
Vinblastine—CYP2D6—Cyclosporine—psoriasis	0.0058	0.0191	CbGbCtD
Vinblastine—CYP3A4—Cholecalciferol—psoriasis	0.00562	0.0185	CbGbCtD
Vinblastine—CYP3A4—Mycophenolate mofetil—psoriasis	0.00487	0.0161	CbGbCtD
Vinblastine—CYP3A4—Triamcinolone—psoriasis	0.00487	0.0161	CbGbCtD
Vinblastine—CYP3A4—Betamethasone—psoriasis	0.00418	0.0138	CbGbCtD
Vinblastine—CYP3A4—Prednisolone—psoriasis	0.00412	0.0136	CbGbCtD
Vinblastine—ABCB1—Dexamethasone—psoriasis	0.00406	0.0134	CbGbCtD
Vinblastine—CYP3A4—Hydrocortisone—psoriasis	0.00391	0.0129	CbGbCtD
Vinblastine—CYP3A4—Prednisone—psoriasis	0.00389	0.0128	CbGbCtD
Vinblastine—CYP2D6—Dexamethasone—psoriasis	0.00382	0.0126	CbGbCtD
Vinblastine—CYP3A4—Cyclosporine—psoriasis	0.00369	0.0122	CbGbCtD
Vinblastine—ABCB1—Methotrexate—psoriasis	0.00326	0.0107	CbGbCtD
Vinblastine—JUN—skin epidermis—psoriasis	0.003	0.0948	CbGeAlD
Vinblastine—CYP3A4—Dexamethasone—psoriasis	0.00243	0.00801	CbGbCtD
Vinblastine—JUN—endothelium—psoriasis	0.00217	0.0688	CbGeAlD
Vinblastine—TUBB4B—skin epidermis—psoriasis	0.00202	0.0638	CbGeAlD
Vinblastine—TUBG1—skin of body—psoriasis	0.00162	0.0512	CbGeAlD
Vinblastine—TUBD1—tendon—psoriasis	0.00147	0.0465	CbGeAlD
Vinblastine—TUBE1—tendon—psoriasis	0.00138	0.0436	CbGeAlD
Vinblastine—TUBG1—tendon—psoriasis	0.00123	0.039	CbGeAlD
Vinblastine—TUBA1A—skin of body—psoriasis	0.000937	0.0297	CbGeAlD
Vinblastine—JUN—skin of body—psoriasis	0.000928	0.0294	CbGeAlD
Vinblastine—TUBB4A—skin of body—psoriasis	0.000801	0.0253	CbGeAlD
Vinblastine—TUBB2A—skin of body—psoriasis	0.000729	0.0231	CbGeAlD
Vinblastine—TUBB6—skin of body—psoriasis	0.000719	0.0227	CbGeAlD
Vinblastine—TUBA1A—tendon—psoriasis	0.000714	0.0226	CbGeAlD
Vinblastine—JUN—tendon—psoriasis	0.000707	0.0224	CbGeAlD
Vinblastine—TUBA1A—Vitamin A—Acitretin—psoriasis	0.000684	0.16	CbGdCrCtD
Vinblastine—TUBB4B—skin of body—psoriasis	0.000625	0.0198	CbGeAlD
Vinblastine—TUBB4A—tendon—psoriasis	0.00061	0.0193	CbGeAlD
Vinblastine—TUBB2B—tendon—psoriasis	0.000589	0.0187	CbGeAlD
Vinblastine—TUBB—tendon—psoriasis	0.000558	0.0176	CbGeAlD
Vinblastine—TUBB2A—tendon—psoriasis	0.000555	0.0176	CbGeAlD
Vinblastine—TUBB6—tendon—psoriasis	0.000547	0.0173	CbGeAlD
Vinblastine—TUBA1A—Isotretinoin—Acitretin—psoriasis	0.000478	0.112	CbGdCrCtD
Vinblastine—TUBA1A—Tretinoin—Acitretin—psoriasis	0.000478	0.112	CbGdCrCtD
Vinblastine—TUBA1A—Alitretinoin—Acitretin—psoriasis	0.000478	0.112	CbGdCrCtD
Vinblastine—TUBB4B—tendon—psoriasis	0.000476	0.0151	CbGeAlD
Vinblastine—ABCC2—tendon—psoriasis	0.000385	0.0122	CbGeAlD
Vinblastine—ABCC1—tendon—psoriasis	0.000339	0.0107	CbGeAlD
Vinblastine—TUBB6—Vitamin A—Acitretin—psoriasis	0.000263	0.0615	CbGdCrCtD
Vinblastine—TUBB6—Isotretinoin—Acitretin—psoriasis	0.000184	0.043	CbGdCrCtD
Vinblastine—TUBB6—Alitretinoin—Acitretin—psoriasis	0.000184	0.043	CbGdCrCtD
Vinblastine—TUBB6—Tretinoin—Acitretin—psoriasis	0.000184	0.043	CbGdCrCtD
Vinblastine—Diarrhoea—Fluocinolone Acetonide—psoriasis	0.000184	0.00198	CcSEcCtD
Vinblastine—Haemorrhage—Prednisolone—psoriasis	0.000184	0.00198	CcSEcCtD
Vinblastine—Discomfort—Mycophenolic acid—psoriasis	0.000183	0.00197	CcSEcCtD
Vinblastine—Constipation—Hydroxyurea—psoriasis	0.000181	0.00195	CcSEcCtD
Vinblastine—Pain—Hydroxyurea—psoriasis	0.000181	0.00195	CcSEcCtD
Vinblastine—Haemoglobin—Hydrocortisone—psoriasis	0.00018	0.00195	CcSEcCtD
Vinblastine—Nausea—Calcitriol—psoriasis	0.00018	0.00194	CcSEcCtD
Vinblastine—Haemorrhage—Hydrocortisone—psoriasis	0.00018	0.00194	CcSEcCtD
Vinblastine—Alopecia—Cyclosporine—psoriasis	0.000179	0.00192	CcSEcCtD
Vinblastine—Dizziness—Acitretin—psoriasis	0.000178	0.00192	CcSEcCtD
Vinblastine—Dizziness—Fluocinolone Acetonide—psoriasis	0.000178	0.00192	CcSEcCtD
Vinblastine—Feeling abnormal—Hydroxyurea—psoriasis	0.000175	0.00188	CcSEcCtD
Vinblastine—Alopecia—Mycophenolate mofetil—psoriasis	0.000174	0.00188	CcSEcCtD
Vinblastine—Thrombocytopenia—Mycophenolic acid—psoriasis	0.000174	0.00187	CcSEcCtD
Vinblastine—Vomiting—Acitretin—psoriasis	0.000172	0.00185	CcSEcCtD
Vinblastine—Vomiting—Fluocinolone Acetonide—psoriasis	0.000171	0.00184	CcSEcCtD
Vinblastine—Haemoglobin—Triamcinolone—psoriasis	0.00017	0.00183	CcSEcCtD
Vinblastine—Anorexia—Mycophenolic acid—psoriasis	0.000169	0.00182	CcSEcCtD
Vinblastine—Haemorrhage—Triamcinolone—psoriasis	0.000169	0.00182	CcSEcCtD
Vinblastine—Headache—Acitretin—psoriasis	0.000169	0.00182	CcSEcCtD
Vinblastine—Headache—Fluocinolone Acetonide—psoriasis	0.000169	0.00182	CcSEcCtD
Vinblastine—Acute coronary syndrome—Betamethasone—psoriasis	0.000168	0.00182	CcSEcCtD
Vinblastine—Acute coronary syndrome—Dexamethasone—psoriasis	0.000168	0.00182	CcSEcCtD
Vinblastine—Pharyngitis—Triamcinolone—psoriasis	0.000168	0.00181	CcSEcCtD
Vinblastine—Myocardial infarction—Betamethasone—psoriasis	0.000167	0.00181	CcSEcCtD
Vinblastine—Myocardial infarction—Dexamethasone—psoriasis	0.000167	0.00181	CcSEcCtD
Vinblastine—Neuropathy peripheral—Betamethasone—psoriasis	0.000167	0.00181	CcSEcCtD
Vinblastine—Neuropathy peripheral—Dexamethasone—psoriasis	0.000167	0.00181	CcSEcCtD
Vinblastine—Cerebrovascular accident—Methotrexate—psoriasis	0.000165	0.00178	CcSEcCtD
Vinblastine—Ill-defined disorder—Cyclosporine—psoriasis	0.000163	0.00176	CcSEcCtD
Vinblastine—Anaemia—Cyclosporine—psoriasis	0.000163	0.00175	CcSEcCtD
Vinblastine—Nausea—Acitretin—psoriasis	0.00016	0.00173	CcSEcCtD
Vinblastine—Nausea—Fluocinolone Acetonide—psoriasis	0.00016	0.00172	CcSEcCtD
Vinblastine—Paraesthesia—Mycophenolic acid—psoriasis	0.000159	0.00172	CcSEcCtD
Vinblastine—Ill-defined disorder—Mycophenolate mofetil—psoriasis	0.000159	0.00172	CcSEcCtD
Vinblastine—Malaise—Cyclosporine—psoriasis	0.000159	0.00171	CcSEcCtD
Vinblastine—Anaemia—Mycophenolate mofetil—psoriasis	0.000159	0.00171	CcSEcCtD
Vinblastine—Vertigo—Cyclosporine—psoriasis	0.000158	0.0017	CcSEcCtD
Vinblastine—Leukopenia—Cyclosporine—psoriasis	0.000157	0.0017	CcSEcCtD
Vinblastine—Hypersensitivity—Hydroxyurea—psoriasis	0.000156	0.00168	CcSEcCtD
Vinblastine—Malaise—Mycophenolate mofetil—psoriasis	0.000155	0.00167	CcSEcCtD
Vinblastine—Decreased appetite—Mycophenolic acid—psoriasis	0.000154	0.00166	CcSEcCtD
Vinblastine—Haemoglobin—Betamethasone—psoriasis	0.000154	0.00166	CcSEcCtD
Vinblastine—Haemoglobin—Dexamethasone—psoriasis	0.000154	0.00166	CcSEcCtD
Vinblastine—Vertigo—Mycophenolate mofetil—psoriasis	0.000154	0.00166	CcSEcCtD
Vinblastine—Leukopenia—Mycophenolate mofetil—psoriasis	0.000154	0.00166	CcSEcCtD
Vinblastine—Haemorrhage—Dexamethasone—psoriasis	0.000153	0.00165	CcSEcCtD
Vinblastine—Haemorrhage—Betamethasone—psoriasis	0.000153	0.00165	CcSEcCtD
Vinblastine—Convulsion—Cyclosporine—psoriasis	0.000152	0.00164	CcSEcCtD
Vinblastine—Asthenia—Hydroxyurea—psoriasis	0.000152	0.00164	CcSEcCtD
Vinblastine—Hypertension—Cyclosporine—psoriasis	0.000152	0.00164	CcSEcCtD
Vinblastine—Constipation—Mycophenolic acid—psoriasis	0.000152	0.00164	CcSEcCtD
Vinblastine—Pain—Mycophenolic acid—psoriasis	0.000152	0.00164	CcSEcCtD
Vinblastine—Convulsion—Mycophenolate mofetil—psoriasis	0.000149	0.0016	CcSEcCtD
Vinblastine—Ill-defined disorder—Prednisolone—psoriasis	0.000148	0.0016	CcSEcCtD
Vinblastine—Depression—Prednisone—psoriasis	0.000148	0.0016	CcSEcCtD
Vinblastine—Hypertension—Mycophenolate mofetil—psoriasis	0.000148	0.0016	CcSEcCtD
Vinblastine—Discomfort—Cyclosporine—psoriasis	0.000148	0.00159	CcSEcCtD
Vinblastine—Acute coronary syndrome—Prednisone—psoriasis	0.000147	0.00158	CcSEcCtD
Vinblastine—Feeling abnormal—Mycophenolic acid—psoriasis	0.000146	0.00158	CcSEcCtD
Vinblastine—Myocardial infarction—Prednisone—psoriasis	0.000146	0.00157	CcSEcCtD
Vinblastine—Neuropathy peripheral—Prednisone—psoriasis	0.000146	0.00157	CcSEcCtD
Vinblastine—Gastrointestinal pain—Mycophenolic acid—psoriasis	0.000145	0.00156	CcSEcCtD
Vinblastine—Ill-defined disorder—Hydrocortisone—psoriasis	0.000145	0.00156	CcSEcCtD
Vinblastine—Diarrhoea—Hydroxyurea—psoriasis	0.000145	0.00156	CcSEcCtD
Vinblastine—Malaise—Prednisolone—psoriasis	0.000144	0.00156	CcSEcCtD
Vinblastine—Discomfort—Mycophenolate mofetil—psoriasis	0.000144	0.00156	CcSEcCtD
Vinblastine—Vertigo—Prednisolone—psoriasis	0.000144	0.00155	CcSEcCtD
Vinblastine—Malaise—Hydrocortisone—psoriasis	0.000141	0.00152	CcSEcCtD
Vinblastine—Thrombocytopenia—Cyclosporine—psoriasis	0.000141	0.00151	CcSEcCtD
Vinblastine—Vertigo—Hydrocortisone—psoriasis	0.00014	0.00151	CcSEcCtD
Vinblastine—Abdominal pain—Mycophenolic acid—psoriasis	0.00014	0.00151	CcSEcCtD
Vinblastine—Dizziness—Hydroxyurea—psoriasis	0.00014	0.00151	CcSEcCtD
Vinblastine—Convulsion—Prednisolone—psoriasis	0.000139	0.00149	CcSEcCtD
Vinblastine—Hypertension—Prednisolone—psoriasis	0.000138	0.00149	CcSEcCtD
Vinblastine—Thrombocytopenia—Mycophenolate mofetil—psoriasis	0.000137	0.00148	CcSEcCtD
Vinblastine—Anorexia—Cyclosporine—psoriasis	0.000137	0.00147	CcSEcCtD
Vinblastine—Ill-defined disorder—Triamcinolone—psoriasis	0.000137	0.00147	CcSEcCtD
Vinblastine—Alopecia—Dexamethasone—psoriasis	0.000136	0.00146	CcSEcCtD
Vinblastine—Alopecia—Betamethasone—psoriasis	0.000136	0.00146	CcSEcCtD
Vinblastine—Convulsion—Hydrocortisone—psoriasis	0.000135	0.00146	CcSEcCtD
Vinblastine—Hypertension—Hydrocortisone—psoriasis	0.000135	0.00145	CcSEcCtD
Vinblastine—Vomiting—Hydroxyurea—psoriasis	0.000135	0.00145	CcSEcCtD
Vinblastine—Discomfort—Prednisolone—psoriasis	0.000135	0.00145	CcSEcCtD
Vinblastine—Haemoglobin—Prednisone—psoriasis	0.000134	0.00145	CcSEcCtD
Vinblastine—Haemorrhage—Prednisone—psoriasis	0.000134	0.00144	CcSEcCtD
Vinblastine—Anorexia—Mycophenolate mofetil—psoriasis	0.000133	0.00144	CcSEcCtD
Vinblastine—Malaise—Triamcinolone—psoriasis	0.000133	0.00143	CcSEcCtD
Vinblastine—Headache—Hydroxyurea—psoriasis	0.000133	0.00143	CcSEcCtD
Vinblastine—Pancytopenia—Methotrexate—psoriasis	0.000132	0.00143	CcSEcCtD
Vinblastine—Vertigo—Triamcinolone—psoriasis	0.000132	0.00143	CcSEcCtD
Vinblastine—Discomfort—Hydrocortisone—psoriasis	0.000131	0.00142	CcSEcCtD
Vinblastine—JUN—Dexamethasone—Clobetasol propionate—psoriasis	0.000131	0.0305	CbGdCrCtD
Vinblastine—JUN—Betamethasone—Clobetasol propionate—psoriasis	0.000131	0.0305	CbGdCrCtD
Vinblastine—Paraesthesia—Cyclosporine—psoriasis	0.000129	0.00139	CcSEcCtD
Vinblastine—Convulsion—Triamcinolone—psoriasis	0.000128	0.00137	CcSEcCtD
Vinblastine—Asthenia—Mycophenolic acid—psoriasis	0.000127	0.00137	CcSEcCtD
Vinblastine—Hypertension—Triamcinolone—psoriasis	0.000127	0.00137	CcSEcCtD
Vinblastine—Nausea—Hydroxyurea—psoriasis	0.000126	0.00136	CcSEcCtD
Vinblastine—Paraesthesia—Mycophenolate mofetil—psoriasis	0.000126	0.00136	CcSEcCtD
Vinblastine—Decreased appetite—Cyclosporine—psoriasis	0.000125	0.00134	CcSEcCtD
Vinblastine—Depression—Methotrexate—psoriasis	0.000124	0.00134	CcSEcCtD
Vinblastine—Ill-defined disorder—Dexamethasone—psoriasis	0.000124	0.00134	CcSEcCtD
Vinblastine—Ill-defined disorder—Betamethasone—psoriasis	0.000124	0.00134	CcSEcCtD
Vinblastine—Discomfort—Triamcinolone—psoriasis	0.000124	0.00133	CcSEcCtD
Vinblastine—Constipation—Cyclosporine—psoriasis	0.000123	0.00132	CcSEcCtD
Vinblastine—Pain—Cyclosporine—psoriasis	0.000123	0.00132	CcSEcCtD
Vinblastine—Decreased appetite—Mycophenolate mofetil—psoriasis	0.000122	0.00131	CcSEcCtD
Vinblastine—Anorexia—Hydrocortisone—psoriasis	0.000122	0.00131	CcSEcCtD
Vinblastine—Diarrhoea—Mycophenolic acid—psoriasis	0.000121	0.00131	CcSEcCtD
Vinblastine—Malaise—Betamethasone—psoriasis	0.00012	0.0013	CcSEcCtD
Vinblastine—Malaise—Dexamethasone—psoriasis	0.00012	0.0013	CcSEcCtD
Vinblastine—Vertigo—Dexamethasone—psoriasis	0.00012	0.00129	CcSEcCtD
Vinblastine—Vertigo—Betamethasone—psoriasis	0.00012	0.00129	CcSEcCtD
Vinblastine—Constipation—Mycophenolate mofetil—psoriasis	0.00012	0.00129	CcSEcCtD
Vinblastine—Pain—Mycophenolate mofetil—psoriasis	0.00012	0.00129	CcSEcCtD
Vinblastine—Feeling abnormal—Cyclosporine—psoriasis	0.000118	0.00127	CcSEcCtD
Vinblastine—Alopecia—Prednisone—psoriasis	0.000118	0.00127	CcSEcCtD
Vinblastine—Gastrointestinal pain—Cyclosporine—psoriasis	0.000117	0.00127	CcSEcCtD
Vinblastine—Dizziness—Mycophenolic acid—psoriasis	0.000117	0.00126	CcSEcCtD
Vinblastine—Paraesthesia—Prednisolone—psoriasis	0.000117	0.00126	CcSEcCtD
Vinblastine—Agranulocytosis—Methotrexate—psoriasis	0.000116	0.00125	CcSEcCtD
Vinblastine—Convulsion—Betamethasone—psoriasis	0.000116	0.00125	CcSEcCtD
Vinblastine—Convulsion—Dexamethasone—psoriasis	0.000116	0.00125	CcSEcCtD
Vinblastine—Feeling abnormal—Mycophenolate mofetil—psoriasis	0.000115	0.00124	CcSEcCtD
Vinblastine—Hypertension—Dexamethasone—psoriasis	0.000115	0.00124	CcSEcCtD
Vinblastine—Hypertension—Betamethasone—psoriasis	0.000115	0.00124	CcSEcCtD
Vinblastine—Paraesthesia—Hydrocortisone—psoriasis	0.000115	0.00123	CcSEcCtD
Vinblastine—Gastrointestinal pain—Mycophenolate mofetil—psoriasis	0.000114	0.00123	CcSEcCtD
Vinblastine—Abdominal pain—Cyclosporine—psoriasis	0.000113	0.00122	CcSEcCtD
Vinblastine—Vomiting—Mycophenolic acid—psoriasis	0.000113	0.00122	CcSEcCtD
Vinblastine—Discomfort—Betamethasone—psoriasis	0.000112	0.00121	CcSEcCtD
Vinblastine—Discomfort—Dexamethasone—psoriasis	0.000112	0.00121	CcSEcCtD
Vinblastine—Haemoglobin—Methotrexate—psoriasis	0.000112	0.00121	CcSEcCtD
Vinblastine—Pain—Prednisolone—psoriasis	0.000112	0.0012	CcSEcCtD
Vinblastine—Haemorrhage—Methotrexate—psoriasis	0.000112	0.0012	CcSEcCtD
Vinblastine—Headache—Mycophenolic acid—psoriasis	0.000111	0.0012	CcSEcCtD
Vinblastine—Decreased appetite—Hydrocortisone—psoriasis	0.000111	0.0012	CcSEcCtD
Vinblastine—Pharyngitis—Methotrexate—psoriasis	0.000111	0.00119	CcSEcCtD
Vinblastine—Abdominal pain—Mycophenolate mofetil—psoriasis	0.000111	0.00119	CcSEcCtD
Vinblastine—Pain—Hydrocortisone—psoriasis	0.000109	0.00118	CcSEcCtD
Vinblastine—Ill-defined disorder—Prednisone—psoriasis	0.000108	0.00116	CcSEcCtD
Vinblastine—Paraesthesia—Triamcinolone—psoriasis	0.000108	0.00116	CcSEcCtD
Vinblastine—Feeling abnormal—Prednisolone—psoriasis	0.000108	0.00116	CcSEcCtD
Vinblastine—Anaemia—Prednisone—psoriasis	0.000107	0.00116	CcSEcCtD
Vinblastine—Thrombocytopenia—Betamethasone—psoriasis	0.000107	0.00115	CcSEcCtD
Vinblastine—Thrombocytopenia—Dexamethasone—psoriasis	0.000107	0.00115	CcSEcCtD
Vinblastine—Hypersensitivity—Cyclosporine—psoriasis	0.000106	0.00114	CcSEcCtD
Vinblastine—Nausea—Mycophenolic acid—psoriasis	0.000105	0.00114	CcSEcCtD
Vinblastine—Feeling abnormal—Hydrocortisone—psoriasis	0.000105	0.00113	CcSEcCtD
Vinblastine—Malaise—Prednisone—psoriasis	0.000105	0.00113	CcSEcCtD
Vinblastine—JUN—Betamethasone—Beclomethasone—psoriasis	0.000105	0.0244	CbGdCrCtD
Vinblastine—JUN—Betamethasone—Fluocinonide—psoriasis	0.000105	0.0244	CbGdCrCtD
Vinblastine—JUN—Dexamethasone—Beclomethasone—psoriasis	0.000105	0.0244	CbGdCrCtD
Vinblastine—JUN—Dexamethasone—Fluocinonide—psoriasis	0.000105	0.0244	CbGdCrCtD
Vinblastine—Vertigo—Prednisone—psoriasis	0.000104	0.00113	CcSEcCtD
Vinblastine—Gastrointestinal pain—Hydrocortisone—psoriasis	0.000104	0.00112	CcSEcCtD
Vinblastine—Anorexia—Dexamethasone—psoriasis	0.000104	0.00112	CcSEcCtD
Vinblastine—Anorexia—Betamethasone—psoriasis	0.000104	0.00112	CcSEcCtD
Vinblastine—Hypersensitivity—Mycophenolate mofetil—psoriasis	0.000103	0.00111	CcSEcCtD
Vinblastine—Asthenia—Cyclosporine—psoriasis	0.000103	0.00111	CcSEcCtD
Vinblastine—Pain—Triamcinolone—psoriasis	0.000103	0.00111	CcSEcCtD
Vinblastine—JUN—Dexamethasone—Fluocinolone Acetonide—psoriasis	0.000102	0.0237	CbGdCrCtD
Vinblastine—JUN—Betamethasone—Fluocinolone Acetonide—psoriasis	0.000102	0.0237	CbGdCrCtD
Vinblastine—Abdominal pain—Hydrocortisone—psoriasis	0.000101	0.00109	CcSEcCtD
Vinblastine—Convulsion—Prednisone—psoriasis	0.000101	0.00109	CcSEcCtD
Vinblastine—Asthenia—Mycophenolate mofetil—psoriasis	0.0001	0.00108	CcSEcCtD
Vinblastine—Hypertension—Prednisone—psoriasis	0.0001	0.00108	CcSEcCtD
Vinblastine—Feeling abnormal—Triamcinolone—psoriasis	9.9e-05	0.00107	CcSEcCtD
Vinblastine—Alopecia—Methotrexate—psoriasis	9.86e-05	0.00106	CcSEcCtD
Vinblastine—Diarrhoea—Cyclosporine—psoriasis	9.82e-05	0.00106	CcSEcCtD
Vinblastine—Paraesthesia—Betamethasone—psoriasis	9.79e-05	0.00105	CcSEcCtD
Vinblastine—Paraesthesia—Dexamethasone—psoriasis	9.79e-05	0.00105	CcSEcCtD
Vinblastine—Discomfort—Prednisone—psoriasis	9.78e-05	0.00105	CcSEcCtD
Vinblastine—Hypersensitivity—Prednisolone—psoriasis	9.62e-05	0.00104	CcSEcCtD
Vinblastine—Diarrhoea—Mycophenolate mofetil—psoriasis	9.58e-05	0.00103	CcSEcCtD
Vinblastine—Dizziness—Cyclosporine—psoriasis	9.49e-05	0.00102	CcSEcCtD
Vinblastine—Decreased appetite—Dexamethasone—psoriasis	9.47e-05	0.00102	CcSEcCtD
Vinblastine—Decreased appetite—Betamethasone—psoriasis	9.47e-05	0.00102	CcSEcCtD
Vinblastine—Hypersensitivity—Hydrocortisone—psoriasis	9.4e-05	0.00101	CcSEcCtD
Vinblastine—Pain—Dexamethasone—psoriasis	9.32e-05	0.001	CcSEcCtD
Vinblastine—Pain—Betamethasone—psoriasis	9.32e-05	0.001	CcSEcCtD
Vinblastine—Dizziness—Mycophenolate mofetil—psoriasis	9.26e-05	0.000998	CcSEcCtD
Vinblastine—Asthenia—Hydrocortisone—psoriasis	9.15e-05	0.000986	CcSEcCtD
Vinblastine—Vomiting—Cyclosporine—psoriasis	9.13e-05	0.000984	CcSEcCtD
Vinblastine—Anorexia—Prednisone—psoriasis	9.05e-05	0.000975	CcSEcCtD
Vinblastine—Ill-defined disorder—Methotrexate—psoriasis	9.02e-05	0.000972	CcSEcCtD
Vinblastine—Headache—Cyclosporine—psoriasis	8.99e-05	0.000969	CcSEcCtD
Vinblastine—Anaemia—Methotrexate—psoriasis	8.98e-05	0.000968	CcSEcCtD
Vinblastine—Feeling abnormal—Dexamethasone—psoriasis	8.98e-05	0.000968	CcSEcCtD
Vinblastine—Feeling abnormal—Betamethasone—psoriasis	8.98e-05	0.000968	CcSEcCtD
Vinblastine—Gastrointestinal pain—Betamethasone—psoriasis	8.91e-05	0.000961	CcSEcCtD
Vinblastine—Gastrointestinal pain—Dexamethasone—psoriasis	8.91e-05	0.000961	CcSEcCtD
Vinblastine—Vomiting—Mycophenolate mofetil—psoriasis	8.9e-05	0.00096	CcSEcCtD
Vinblastine—Hypersensitivity—Triamcinolone—psoriasis	8.85e-05	0.000954	CcSEcCtD
Vinblastine—Headache—Mycophenolate mofetil—psoriasis	8.77e-05	0.000945	CcSEcCtD
Vinblastine—Malaise—Methotrexate—psoriasis	8.76e-05	0.000945	CcSEcCtD
Vinblastine—Vertigo—Methotrexate—psoriasis	8.73e-05	0.000941	CcSEcCtD
Vinblastine—Diarrhoea—Hydrocortisone—psoriasis	8.73e-05	0.000941	CcSEcCtD
Vinblastine—Leukopenia—Methotrexate—psoriasis	8.7e-05	0.000938	CcSEcCtD
Vinblastine—Dizziness—Prednisolone—psoriasis	8.64e-05	0.000931	CcSEcCtD
Vinblastine—Asthenia—Triamcinolone—psoriasis	8.62e-05	0.000929	CcSEcCtD
Vinblastine—Abdominal pain—Dexamethasone—psoriasis	8.61e-05	0.000929	CcSEcCtD
Vinblastine—Abdominal pain—Betamethasone—psoriasis	8.61e-05	0.000929	CcSEcCtD
Vinblastine—Nausea—Cyclosporine—psoriasis	8.52e-05	0.000919	CcSEcCtD
Vinblastine—Paraesthesia—Prednisone—psoriasis	8.52e-05	0.000919	CcSEcCtD
Vinblastine—Dizziness—Hydrocortisone—psoriasis	8.43e-05	0.000909	CcSEcCtD
Vinblastine—Convulsion—Methotrexate—psoriasis	8.42e-05	0.000908	CcSEcCtD
Vinblastine—Nausea—Mycophenolate mofetil—psoriasis	8.32e-05	0.000896	CcSEcCtD
Vinblastine—Decreased appetite—Prednisone—psoriasis	8.25e-05	0.000889	CcSEcCtD
Vinblastine—Headache—Prednisolone—psoriasis	8.18e-05	0.000882	CcSEcCtD
Vinblastine—Discomfort—Methotrexate—psoriasis	8.17e-05	0.000881	CcSEcCtD
Vinblastine—Constipation—Prednisone—psoriasis	8.12e-05	0.000875	CcSEcCtD
Vinblastine—Vomiting—Hydrocortisone—psoriasis	8.11e-05	0.000874	CcSEcCtD
Vinblastine—Headache—Hydrocortisone—psoriasis	7.99e-05	0.000861	CcSEcCtD
Vinblastine—Dizziness—Triamcinolone—psoriasis	7.94e-05	0.000856	CcSEcCtD
Vinblastine—Feeling abnormal—Prednisone—psoriasis	7.82e-05	0.000843	CcSEcCtD
Vinblastine—Asthenia—Betamethasone—psoriasis	7.82e-05	0.000843	CcSEcCtD
Vinblastine—Asthenia—Dexamethasone—psoriasis	7.82e-05	0.000843	CcSEcCtD
Vinblastine—Thrombocytopenia—Methotrexate—psoriasis	7.77e-05	0.000837	CcSEcCtD
Vinblastine—Gastrointestinal pain—Prednisone—psoriasis	7.76e-05	0.000837	CcSEcCtD
Vinblastine—Nausea—Prednisolone—psoriasis	7.76e-05	0.000836	CcSEcCtD
Vinblastine—Vomiting—Triamcinolone—psoriasis	7.64e-05	0.000823	CcSEcCtD
Vinblastine—Nausea—Hydrocortisone—psoriasis	7.58e-05	0.000817	CcSEcCtD
Vinblastine—Anorexia—Methotrexate—psoriasis	7.56e-05	0.000815	CcSEcCtD
Vinblastine—Headache—Triamcinolone—psoriasis	7.52e-05	0.000811	CcSEcCtD
Vinblastine—Abdominal pain—Prednisone—psoriasis	7.5e-05	0.000809	CcSEcCtD
Vinblastine—Diarrhoea—Betamethasone—psoriasis	7.46e-05	0.000804	CcSEcCtD
Vinblastine—Diarrhoea—Dexamethasone—psoriasis	7.46e-05	0.000804	CcSEcCtD
Vinblastine—Dizziness—Dexamethasone—psoriasis	7.21e-05	0.000777	CcSEcCtD
Vinblastine—Dizziness—Betamethasone—psoriasis	7.21e-05	0.000777	CcSEcCtD
Vinblastine—Nausea—Triamcinolone—psoriasis	7.13e-05	0.000769	CcSEcCtD
Vinblastine—Paraesthesia—Methotrexate—psoriasis	7.12e-05	0.000768	CcSEcCtD
Vinblastine—Hypersensitivity—Prednisone—psoriasis	6.99e-05	0.000754	CcSEcCtD
Vinblastine—Vomiting—Betamethasone—psoriasis	6.93e-05	0.000747	CcSEcCtD
Vinblastine—Vomiting—Dexamethasone—psoriasis	6.93e-05	0.000747	CcSEcCtD
Vinblastine—Decreased appetite—Methotrexate—psoriasis	6.89e-05	0.000743	CcSEcCtD
Vinblastine—Headache—Dexamethasone—psoriasis	6.83e-05	0.000736	CcSEcCtD
Vinblastine—Headache—Betamethasone—psoriasis	6.83e-05	0.000736	CcSEcCtD
Vinblastine—Asthenia—Prednisone—psoriasis	6.81e-05	0.000734	CcSEcCtD
Vinblastine—Pain—Methotrexate—psoriasis	6.78e-05	0.000731	CcSEcCtD
Vinblastine—Feeling abnormal—Methotrexate—psoriasis	6.54e-05	0.000705	CcSEcCtD
Vinblastine—Diarrhoea—Prednisone—psoriasis	6.49e-05	0.0007	CcSEcCtD
Vinblastine—Gastrointestinal pain—Methotrexate—psoriasis	6.49e-05	0.000699	CcSEcCtD
Vinblastine—Nausea—Dexamethasone—psoriasis	6.47e-05	0.000698	CcSEcCtD
Vinblastine—Nausea—Betamethasone—psoriasis	6.47e-05	0.000698	CcSEcCtD
Vinblastine—Dizziness—Prednisone—psoriasis	6.28e-05	0.000676	CcSEcCtD
Vinblastine—Abdominal pain—Methotrexate—psoriasis	6.27e-05	0.000676	CcSEcCtD
Vinblastine—Vomiting—Prednisone—psoriasis	6.03e-05	0.00065	CcSEcCtD
Vinblastine—Headache—Prednisone—psoriasis	5.95e-05	0.000641	CcSEcCtD
Vinblastine—Hypersensitivity—Methotrexate—psoriasis	5.84e-05	0.00063	CcSEcCtD
Vinblastine—Asthenia—Methotrexate—psoriasis	5.69e-05	0.000613	CcSEcCtD
Vinblastine—Nausea—Prednisone—psoriasis	5.64e-05	0.000608	CcSEcCtD
Vinblastine—Diarrhoea—Methotrexate—psoriasis	5.43e-05	0.000585	CcSEcCtD
Vinblastine—Dizziness—Methotrexate—psoriasis	5.24e-05	0.000565	CcSEcCtD
Vinblastine—JUN—Dexamethasone—Hydrocortisone—psoriasis	5.14e-05	0.012	CbGdCrCtD
Vinblastine—JUN—Betamethasone—Hydrocortisone—psoriasis	5.14e-05	0.012	CbGdCrCtD
Vinblastine—Vomiting—Methotrexate—psoriasis	5.04e-05	0.000544	CcSEcCtD
Vinblastine—CYP3A4—Tryptophan metabolism—CAT—psoriasis	5e-05	0.00101	CbGpPWpGaD
Vinblastine—ABCB1—Allograft Rejection—IL10—psoriasis	4.98e-05	0.00101	CbGpPWpGaD
Vinblastine—Headache—Methotrexate—psoriasis	4.97e-05	0.000536	CcSEcCtD
Vinblastine—TUBB3—Metabolism of proteins—ACE—psoriasis	4.97e-05	0.001	CbGpPWpGaD
Vinblastine—ABCB11—Metabolism of lipids and lipoproteins—CARM1—psoriasis	4.94e-05	0.000998	CbGpPWpGaD
Vinblastine—JUN—Circadian rythm related genes—LEP—psoriasis	4.94e-05	0.000997	CbGpPWpGaD
Vinblastine—JUN—Senescence-Associated Secretory Phenotype (SASP)—NFKB1—psoriasis	4.94e-05	0.000997	CbGpPWpGaD
Vinblastine—JUN—ATF-2 transcription factor network—IL6—psoriasis	4.91e-05	0.000993	CbGpPWpGaD
Vinblastine—ABCB1—Allograft Rejection—IL4—psoriasis	4.84e-05	0.000978	CbGpPWpGaD
Vinblastine—TUBB2A—Metabolism of proteins—ACE—psoriasis	4.81e-05	0.000971	CbGpPWpGaD
Vinblastine—JUN—Integrated Pancreatic Cancer Pathway—NFKBIA—psoriasis	4.79e-05	0.000968	CbGpPWpGaD
Vinblastine—JUN—DNA Damage Response (only ATM dependent)—NFKB1—psoriasis	4.79e-05	0.000968	CbGpPWpGaD
Vinblastine—JUN—Betamethasone—Dexamethasone—psoriasis	4.77e-05	0.0111	CbGdCrCtD
Vinblastine—JUN—Dexamethasone—Betamethasone—psoriasis	4.77e-05	0.0111	CbGdCrCtD
Vinblastine—ABCB1—Allograft Rejection—HLA-B—psoriasis	4.73e-05	0.000956	CbGpPWpGaD
Vinblastine—ABCB1—HIF-1-alpha transcription factor network—LEP—psoriasis	4.73e-05	0.000955	CbGpPWpGaD
Vinblastine—TUBB—Cell Cycle, Mitotic—PCNA—psoriasis	4.71e-05	0.000951	CbGpPWpGaD
Vinblastine—Nausea—Methotrexate—psoriasis	4.71e-05	0.000508	CcSEcCtD
Vinblastine—TUBB1—Metabolism of proteins—ACE—psoriasis	4.7e-05	0.00095	CbGpPWpGaD
Vinblastine—NR5A1—Gene Expression—VDR—psoriasis	4.69e-05	0.000948	CbGpPWpGaD
Vinblastine—JUN—AP-1 transcription factor network—TP53—psoriasis	4.68e-05	0.000946	CbGpPWpGaD
Vinblastine—JUN—Betamethasone—Triamcinolone—psoriasis	4.66e-05	0.0109	CbGdCrCtD
Vinblastine—JUN—Dexamethasone—Triamcinolone—psoriasis	4.66e-05	0.0109	CbGdCrCtD
Vinblastine—JUN—Activated TLR4 signalling—NFKB1—psoriasis	4.66e-05	0.00094	CbGpPWpGaD
Vinblastine—JUN—Circadian rythm related genes—NOS2—psoriasis	4.6e-05	0.000929	CbGpPWpGaD
Vinblastine—JUN—Apoptosis—TNF—psoriasis	4.59e-05	0.000927	CbGpPWpGaD
Vinblastine—ABCB11—Metabolism—CYP2S1—psoriasis	4.51e-05	0.00091	CbGpPWpGaD
Vinblastine—JUN—ErbB1 downstream signaling—STAT3—psoriasis	4.44e-05	0.000896	CbGpPWpGaD
Vinblastine—JUN—Senescence-Associated Secretory Phenotype (SASP)—STAT3—psoriasis	4.44e-05	0.000896	CbGpPWpGaD
Vinblastine—JUN—Dexamethasone—Prednisone—psoriasis	4.42e-05	0.0103	CbGdCrCtD
Vinblastine—JUN—Betamethasone—Prednisone—psoriasis	4.42e-05	0.0103	CbGdCrCtD
Vinblastine—JUN—Regulation of toll-like receptor signaling pathway—CXCL8—psoriasis	4.41e-05	0.00089	CbGpPWpGaD
Vinblastine—ABCB1—HIF-1-alpha transcription factor network—NOS2—psoriasis	4.41e-05	0.00089	CbGpPWpGaD
Vinblastine—ABCB1—Allograft Rejection—HLA-A—psoriasis	4.39e-05	0.000886	CbGpPWpGaD
Vinblastine—JUN—Innate Immune System—IFIH1—psoriasis	4.38e-05	0.000885	CbGpPWpGaD
Vinblastine—JUN—Toll Like Receptor 4 (TLR4) Cascade—NFKB1—psoriasis	4.38e-05	0.000884	CbGpPWpGaD
Vinblastine—NR5A1—Developmental Biology—NFKB1—psoriasis	4.37e-05	0.000882	CbGpPWpGaD
Vinblastine—JUN—Betamethasone—Prednisolone—psoriasis	4.32e-05	0.0101	CbGdCrCtD
Vinblastine—JUN—Dexamethasone—Prednisolone—psoriasis	4.32e-05	0.0101	CbGdCrCtD
Vinblastine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	4.31e-05	0.000871	CbGpPWpGaD
Vinblastine—JUN—Circadian rythm related genes—PPARG—psoriasis	4.3e-05	0.000869	CbGpPWpGaD
Vinblastine—JUN—AP-1 transcription factor network—IL6—psoriasis	4.29e-05	0.000866	CbGpPWpGaD
Vinblastine—JUN—TNF alpha Signaling Pathway—TNF—psoriasis	4.27e-05	0.000862	CbGpPWpGaD
Vinblastine—TUBB4A—Metabolism of proteins—ACE—psoriasis	4.22e-05	0.000853	CbGpPWpGaD
Vinblastine—TUBB—Cell Cycle—PCNA—psoriasis	4.21e-05	0.000851	CbGpPWpGaD
Vinblastine—JUN—Immune System—ERAP1—psoriasis	4.21e-05	0.00085	CbGpPWpGaD
Vinblastine—JUN—Fc epsilon receptor (FCERI) signaling—TYK2—psoriasis	4.17e-05	0.000843	CbGpPWpGaD
Vinblastine—JUN—Innate Immune System—HLA-C—psoriasis	4.15e-05	0.000839	CbGpPWpGaD
Vinblastine—JUN—Glucocorticoid receptor regulatory network—TP53—psoriasis	4.13e-05	0.000833	CbGpPWpGaD
Vinblastine—JUN—Innate Immune System—TNFAIP3—psoriasis	4.1e-05	0.000828	CbGpPWpGaD
Vinblastine—JUN—TRAF6 Mediated Induction of proinflammatory cytokines—IL6—psoriasis	4.06e-05	0.000819	CbGpPWpGaD
Vinblastine—JUN—Apoptosis—TP53—psoriasis	4.05e-05	0.000817	CbGpPWpGaD
Vinblastine—JUN—SIDS Susceptibility Pathways—CXCL8—psoriasis	4.02e-05	0.000812	CbGpPWpGaD
Vinblastine—ABCB1—Allograft Rejection—HLA-DRB1—psoriasis	4.01e-05	0.000809	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism—NDUFA5—psoriasis	3.98e-05	0.000804	CbGpPWpGaD
Vinblastine—TUBA1A—Metabolism of proteins—LEP—psoriasis	3.97e-05	0.000802	CbGpPWpGaD
Vinblastine—NR5A1—Developmental Biology—VEGFA—psoriasis	3.96e-05	0.0008	CbGpPWpGaD
Vinblastine—JUN—Regulation of toll-like receptor signaling pathway—NFKB1—psoriasis	3.94e-05	0.000797	CbGpPWpGaD
Vinblastine—JUN—Toll-like Receptor Signaling Pathway—TNF—psoriasis	3.93e-05	0.000794	CbGpPWpGaD
Vinblastine—NR5A1—Developmental Biology—STAT3—psoriasis	3.92e-05	0.000793	CbGpPWpGaD
Vinblastine—TUBB4A—Cell Cycle, Mitotic—PCNA—psoriasis	3.9e-05	0.000788	CbGpPWpGaD
Vinblastine—JUN—Toll-Like Receptors Cascades—NFKB1—psoriasis	3.9e-05	0.000788	CbGpPWpGaD
Vinblastine—TUBG1—Cell Cycle—TP53—psoriasis	3.89e-05	0.000786	CbGpPWpGaD
Vinblastine—TUBB4B—Metabolism of proteins—ACE—psoriasis	3.86e-05	0.00078	CbGpPWpGaD
Vinblastine—JUN—PDGFR-beta signaling pathway—STAT3—psoriasis	3.86e-05	0.000779	CbGpPWpGaD
Vinblastine—JUN—BDNF signaling pathway—NFKB1—psoriasis	3.83e-05	0.000774	CbGpPWpGaD
Vinblastine—JUN—Apoptosis Modulation and Signaling—TP53—psoriasis	3.8e-05	0.000767	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—HCAR2—psoriasis	3.79e-05	0.000765	CbGpPWpGaD
Vinblastine—JUN—Glucocorticoid receptor regulatory network—IL6—psoriasis	3.78e-05	0.000763	CbGpPWpGaD
Vinblastine—ABCC2—Transmembrane transport of small molecules—CP—psoriasis	3.74e-05	0.000756	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism of lipids and lipoproteins—CARM1—psoriasis	3.71e-05	0.00075	CbGpPWpGaD
Vinblastine—JUN—Immune System—DDX58—psoriasis	3.71e-05	0.000749	CbGpPWpGaD
Vinblastine—ABCC1—Transmembrane transport of small molecules—CP—psoriasis	3.7e-05	0.000747	CbGpPWpGaD
Vinblastine—JUN—Integrated Breast Cancer Pathway—NFKB1—psoriasis	3.69e-05	0.000746	CbGpPWpGaD
Vinblastine—JUN—MyD88 cascade initiated on plasma membrane—IL6—psoriasis	3.67e-05	0.000741	CbGpPWpGaD
Vinblastine—JUN—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—IL6—psoriasis	3.64e-05	0.000734	CbGpPWpGaD
Vinblastine—JUN—Myometrial Relaxation and Contraction Pathways—NFKB1—psoriasis	3.62e-05	0.00073	CbGpPWpGaD
Vinblastine—JUN—SIDS Susceptibility Pathways—NFKB1—psoriasis	3.6e-05	0.000726	CbGpPWpGaD
Vinblastine—ABCC2—Transmembrane transport of small molecules—CARM1—psoriasis	3.57e-05	0.000721	CbGpPWpGaD
Vinblastine—TUBB4B—Cell Cycle, Mitotic—PCNA—psoriasis	3.57e-05	0.000721	CbGpPWpGaD
Vinblastine—JUN—MyD88 dependent cascade initiated on endosome—IL6—psoriasis	3.57e-05	0.000721	CbGpPWpGaD
Vinblastine—ABCC1—Transmembrane transport of small molecules—CARM1—psoriasis	3.53e-05	0.000713	CbGpPWpGaD
Vinblastine—JUN—TCR Signaling Pathway—IL6—psoriasis	3.51e-05	0.000708	CbGpPWpGaD
Vinblastine—JUN—Cellular Senescence—CXCL8—psoriasis	3.49e-05	0.000705	CbGpPWpGaD
Vinblastine—TUBB4A—Cell Cycle—PCNA—psoriasis	3.49e-05	0.000705	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—NDUFA5—psoriasis	3.47e-05	0.0007	CbGpPWpGaD
Vinblastine—JUN—Wnt Signaling Pathway and Pluripotency—TP53—psoriasis	3.47e-05	0.0007	CbGpPWpGaD
Vinblastine—JUN—Innate Immune System—HLA-E—psoriasis	3.45e-05	0.000696	CbGpPWpGaD
Vinblastine—JUN—BDNF signaling pathway—STAT3—psoriasis	3.45e-05	0.000696	CbGpPWpGaD
Vinblastine—JUN—TNF alpha Signaling Pathway—IL6—psoriasis	3.44e-05	0.000696	CbGpPWpGaD
Vinblastine—JUN—Toll Like Receptor 9 (TLR9) Cascade—IL6—psoriasis	3.44e-05	0.000696	CbGpPWpGaD
Vinblastine—NR5A1—Developmental Biology—TNF—psoriasis	3.4e-05	0.000686	CbGpPWpGaD
Vinblastine—JUN—MAPK Signaling Pathway—NFKB1—psoriasis	3.39e-05	0.000685	CbGpPWpGaD
Vinblastine—JUN—MyD88:Mal cascade initiated on plasma membrane—IL6—psoriasis	3.39e-05	0.000684	CbGpPWpGaD
Vinblastine—JUN—Senescence and Autophagy in Cancer—TP53—psoriasis	3.39e-05	0.000684	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism—CYP2S1—psoriasis	3.38e-05	0.000683	CbGpPWpGaD
Vinblastine—JUN—Integrated Breast Cancer Pathway—VEGFA—psoriasis	3.35e-05	0.000677	CbGpPWpGaD
Vinblastine—JUN—Signaling by NOTCH—TP53—psoriasis	3.29e-05	0.000664	CbGpPWpGaD
Vinblastine—JUN—DNA Damage Response (only ATM dependent)—TP53—psoriasis	3.29e-05	0.000664	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—TAGAP—psoriasis	3.29e-05	0.000664	CbGpPWpGaD
Vinblastine—NR5A1—Gene Expression—PPARG—psoriasis	3.27e-05	0.000661	CbGpPWpGaD
Vinblastine—JUN—SIDS Susceptibility Pathways—VEGFA—psoriasis	3.26e-05	0.000659	CbGpPWpGaD
Vinblastine—JUN—Fc epsilon receptor (FCERI) signaling—NFKB1—psoriasis	3.25e-05	0.000657	CbGpPWpGaD
Vinblastine—JUN—MyD88-independent cascade—IL6—psoriasis	3.25e-05	0.000656	CbGpPWpGaD
Vinblastine—SLC22A2—Transmembrane transport of small molecules—CP—psoriasis	3.22e-05	0.000651	CbGpPWpGaD
Vinblastine—TUBB6—Metabolism of proteins—LEP—psoriasis	3.19e-05	0.000645	CbGpPWpGaD
Vinblastine—TUBB2B—Metabolism of proteins—LEP—psoriasis	3.19e-05	0.000645	CbGpPWpGaD
Vinblastine—TUBB4B—Cell Cycle—PCNA—psoriasis	3.19e-05	0.000645	CbGpPWpGaD
Vinblastine—JUN—Toll-like Receptor Signaling Pathway—IL6—psoriasis	3.17e-05	0.000641	CbGpPWpGaD
Vinblastine—JUN—EGF/EGFR Signaling Pathway—STAT3—psoriasis	3.14e-05	0.000633	CbGpPWpGaD
Vinblastine—JUN—Cellular Senescence—NFKB1—psoriasis	3.12e-05	0.000631	CbGpPWpGaD
Vinblastine—JUN—Senescence and Autophagy in Cancer—IL6—psoriasis	3.1e-05	0.000626	CbGpPWpGaD
Vinblastine—JUN—Senescence-Associated Secretory Phenotype (SASP)—IL6—psoriasis	3.1e-05	0.000626	CbGpPWpGaD
Vinblastine—TUBB3—Metabolism of proteins—LEP—psoriasis	3.09e-05	0.000623	CbGpPWpGaD
Vinblastine—SLC22A2—Transmembrane transport of small molecules—CARM1—psoriasis	3.07e-05	0.000621	CbGpPWpGaD
Vinblastine—JUN—Regulation of toll-like receptor signaling pathway—TNF—psoriasis	3.07e-05	0.00062	CbGpPWpGaD
Vinblastine—JUN—Oxidative Stress Induced Senescence—TP53—psoriasis	3.06e-05	0.000619	CbGpPWpGaD
Vinblastine—JUN—Integrated Pancreatic Cancer Pathway—NFKB1—psoriasis	3.06e-05	0.000618	CbGpPWpGaD
Vinblastine—TUBB2A—Metabolism of proteins—LEP—psoriasis	2.99e-05	0.000603	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—CYP2S1—psoriasis	2.95e-05	0.000595	CbGpPWpGaD
Vinblastine—ABCB1—Allograft Rejection—IFNG—psoriasis	2.93e-05	0.000591	CbGpPWpGaD
Vinblastine—JUN—Activated TLR4 signalling—IL6—psoriasis	2.92e-05	0.00059	CbGpPWpGaD
Vinblastine—TUBB1—Metabolism of proteins—LEP—psoriasis	2.92e-05	0.00059	CbGpPWpGaD
Vinblastine—ABCB1—HIF-1-alpha transcription factor network—JUN—psoriasis	2.92e-05	0.00059	CbGpPWpGaD
Vinblastine—JUN—Innate Immune System—SOCS1—psoriasis	2.88e-05	0.000581	CbGpPWpGaD
Vinblastine—JUN—TGF-beta Signaling Pathway—TP53—psoriasis	2.82e-05	0.000569	CbGpPWpGaD
Vinblastine—JUN—Immune System—ITGAL—psoriasis	2.81e-05	0.000567	CbGpPWpGaD
Vinblastine—JUN—Cellular Senescence—STAT3—psoriasis	2.81e-05	0.000567	CbGpPWpGaD
Vinblastine—JUN—SIDS Susceptibility Pathways—TNF—psoriasis	2.8e-05	0.000565	CbGpPWpGaD
Vinblastine—JUN—Focal Adhesion—VEGFA—psoriasis	2.79e-05	0.000563	CbGpPWpGaD
Vinblastine—JUN—Integrated Pancreatic Cancer Pathway—VEGFA—psoriasis	2.78e-05	0.000561	CbGpPWpGaD
Vinblastine—JUN—Toll Like Receptor 4 (TLR4) Cascade—IL6—psoriasis	2.75e-05	0.000555	CbGpPWpGaD
Vinblastine—NR5A1—Developmental Biology—IL6—psoriasis	2.74e-05	0.000554	CbGpPWpGaD
Vinblastine—ABCB1—Allograft Rejection—CXCL8—psoriasis	2.72e-05	0.00055	CbGpPWpGaD
Vinblastine—JUN—Direct p53 effectors—TP53—psoriasis	2.69e-05	0.000543	CbGpPWpGaD
Vinblastine—TUBA1A—Metabolism of proteins—CXCL8—psoriasis	2.64e-05	0.000533	CbGpPWpGaD
Vinblastine—JUN—Cellular responses to stress—CXCL8—psoriasis	2.64e-05	0.000533	CbGpPWpGaD
Vinblastine—JUN—MAPK Signaling Pathway—TNF—psoriasis	2.64e-05	0.000532	CbGpPWpGaD
Vinblastine—JUN—Immune System—REL—psoriasis	2.63e-05	0.000531	CbGpPWpGaD
Vinblastine—TUBB4A—Metabolism of proteins—LEP—psoriasis	2.62e-05	0.00053	CbGpPWpGaD
Vinblastine—ABCB1—HIF-1-alpha transcription factor network—VEGFA—psoriasis	2.55e-05	0.000515	CbGpPWpGaD
Vinblastine—JUN—Immune System—IFIH1—psoriasis	2.55e-05	0.000515	CbGpPWpGaD
Vinblastine—JUN—Integrated Breast Cancer Pathway—TP53—psoriasis	2.53e-05	0.000511	CbGpPWpGaD
Vinblastine—JUN—Regulation of toll-like receptor signaling pathway—IL6—psoriasis	2.48e-05	0.0005	CbGpPWpGaD
Vinblastine—JUN—Innate Immune System—HLA-B—psoriasis	2.46e-05	0.000496	CbGpPWpGaD
Vinblastine—JUN—Toll-Like Receptors Cascades—IL6—psoriasis	2.45e-05	0.000494	CbGpPWpGaD
Vinblastine—JUN—Immune System—HLA-C—psoriasis	2.42e-05	0.000488	CbGpPWpGaD
Vinblastine—TUBB4B—Metabolism of proteins—LEP—psoriasis	2.4e-05	0.000485	CbGpPWpGaD
Vinblastine—JUN—Immune System—TNFAIP3—psoriasis	2.39e-05	0.000482	CbGpPWpGaD
Vinblastine—JUN—Integrated Pancreatic Cancer Pathway—TNF—psoriasis	2.38e-05	0.000481	CbGpPWpGaD
Vinblastine—JUN—Cellular responses to stress—NFKB1—psoriasis	2.36e-05	0.000477	CbGpPWpGaD
Vinblastine—ABCB11—Metabolism of lipids and lipoproteins—APOE—psoriasis	2.36e-05	0.000477	CbGpPWpGaD
Vinblastine—JUN—MAPK Signaling Pathway—TP53—psoriasis	2.32e-05	0.000469	CbGpPWpGaD
Vinblastine—JUN—Myometrial Relaxation and Contraction Pathways—IL6—psoriasis	2.27e-05	0.000458	CbGpPWpGaD
Vinblastine—JUN—SIDS Susceptibility Pathways—IL6—psoriasis	2.26e-05	0.000456	CbGpPWpGaD
Vinblastine—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—psoriasis	2.24e-05	0.000453	CbGpPWpGaD
Vinblastine—ABCB1—Allograft Rejection—VEGFA—psoriasis	2.21e-05	0.000446	CbGpPWpGaD
Vinblastine—ABCB11—Metabolism—CARM1—psoriasis	2.2e-05	0.000444	CbGpPWpGaD
Vinblastine—JUN—Innate Immune System—CRP—psoriasis	2.17e-05	0.000438	CbGpPWpGaD
Vinblastine—JUN—Cellular responses to stress—VEGFA—psoriasis	2.14e-05	0.000433	CbGpPWpGaD
Vinblastine—JUN—Cellular Senescence—TP53—psoriasis	2.14e-05	0.000433	CbGpPWpGaD
Vinblastine—TUBB6—Metabolism of proteins—CXCL8—psoriasis	2.12e-05	0.000429	CbGpPWpGaD
Vinblastine—TUBB2B—Metabolism of proteins—CXCL8—psoriasis	2.12e-05	0.000429	CbGpPWpGaD
Vinblastine—JUN—Cellular responses to stress—STAT3—psoriasis	2.12e-05	0.000429	CbGpPWpGaD
Vinblastine—JUN—Integrated Pancreatic Cancer Pathway—TP53—psoriasis	2.1e-05	0.000424	CbGpPWpGaD
Vinblastine—ABCB11—Metabolism of lipids and lipoproteins—PPARG—psoriasis	2.06e-05	0.000415	CbGpPWpGaD
Vinblastine—TUBB3—Metabolism of proteins—CXCL8—psoriasis	2.05e-05	0.000414	CbGpPWpGaD
Vinblastine—JUN—Fc epsilon receptor (FCERI) signaling—IL6—psoriasis	2.04e-05	0.000412	CbGpPWpGaD
Vinblastine—JUN—Circadian rythm related genes—TP53—psoriasis	2.01e-05	0.000407	CbGpPWpGaD
Vinblastine—JUN—Immune System—HLA-E—psoriasis	2.01e-05	0.000405	CbGpPWpGaD
Vinblastine—TUBB2A—Metabolism of proteins—CXCL8—psoriasis	1.99e-05	0.000401	CbGpPWpGaD
Vinblastine—JUN—Innate Immune System—NFKBIA—psoriasis	1.98e-05	0.0004	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—CCL20—psoriasis	1.97e-05	0.000398	CbGpPWpGaD
Vinblastine—JUN—Cellular Senescence—IL6—psoriasis	1.96e-05	0.000396	CbGpPWpGaD
Vinblastine—TUBA1A—Cell Cycle—TP53—psoriasis	1.94e-05	0.000393	CbGpPWpGaD
Vinblastine—TUBB1—Metabolism of proteins—CXCL8—psoriasis	1.94e-05	0.000392	CbGpPWpGaD
Vinblastine—ABCB1—Allograft Rejection—TNF—psoriasis	1.89e-05	0.000383	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—NDUFA5—psoriasis	1.89e-05	0.000382	CbGpPWpGaD
Vinblastine—ABCB1—Integrated Pancreatic Cancer Pathway—NFKBIA—psoriasis	1.88e-05	0.00038	CbGpPWpGaD
Vinblastine—JUN—Circadian rythm related genes—IL6—psoriasis	1.84e-05	0.000372	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—NDUFA5—psoriasis	1.78e-05	0.00036	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.77e-05	0.000358	CbGpPWpGaD
Vinblastine—ABCB1—Transmembrane transport of small molecules—CP—psoriasis	1.76e-05	0.000355	CbGpPWpGaD
Vinblastine—TUBB4A—Metabolism of proteins—CXCL8—psoriasis	1.74e-05	0.000352	CbGpPWpGaD
Vinblastine—ABCB1—Transmembrane transport of small molecules—CARM1—psoriasis	1.68e-05	0.000339	CbGpPWpGaD
Vinblastine—JUN—Immune System—SOCS1—psoriasis	1.68e-05	0.000339	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism—CARM1—psoriasis	1.65e-05	0.000334	CbGpPWpGaD
Vinblastine—JUN—Innate Immune System—TYK2—psoriasis	1.62e-05	0.000327	CbGpPWpGaD
Vinblastine—JUN—Cellular responses to stress—TP53—psoriasis	1.62e-05	0.000327	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—CYP2S1—psoriasis	1.61e-05	0.000325	CbGpPWpGaD
Vinblastine—TUBB4B—Metabolism of proteins—CXCL8—psoriasis	1.59e-05	0.000322	CbGpPWpGaD
Vinblastine—TUBB—Cell Cycle—TP53—psoriasis	1.55e-05	0.000313	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.54e-05	0.000312	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—CYP2S1—psoriasis	1.52e-05	0.000306	CbGpPWpGaD
Vinblastine—JUN—Immune System—CD8A—psoriasis	1.49e-05	0.0003	CbGpPWpGaD
Vinblastine—JUN—Cellular responses to stress—IL6—psoriasis	1.48e-05	0.000299	CbGpPWpGaD
Vinblastine—JUN—Innate Immune System—CD4—psoriasis	1.47e-05	0.000296	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—CARM1—psoriasis	1.44e-05	0.000291	CbGpPWpGaD
Vinblastine—JUN—Immune System—HLA-B—psoriasis	1.43e-05	0.000289	CbGpPWpGaD
Vinblastine—ABCB11—Metabolism—CAT—psoriasis	1.35e-05	0.000273	CbGpPWpGaD
Vinblastine—JUN—Immune System—HLA-A—psoriasis	1.33e-05	0.000268	CbGpPWpGaD
Vinblastine—TUBB4A—Cell Cycle—TP53—psoriasis	1.28e-05	0.000259	CbGpPWpGaD
Vinblastine—JUN—Immune System—CRP—psoriasis	1.26e-05	0.000255	CbGpPWpGaD
Vinblastine—JUN—Innate Immune System—NFKB1—psoriasis	1.26e-05	0.000255	CbGpPWpGaD
Vinblastine—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—psoriasis	1.25e-05	0.000252	CbGpPWpGaD
Vinblastine—JUN—Immune System—HLA-DRB1—psoriasis	1.21e-05	0.000245	CbGpPWpGaD
Vinblastine—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—psoriasis	1.2e-05	0.000243	CbGpPWpGaD
Vinblastine—TUBB4B—Cell Cycle—TP53—psoriasis	1.17e-05	0.000237	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—NDUFA5—psoriasis	1.17e-05	0.000236	CbGpPWpGaD
Vinblastine—JUN—Immune System—ICAM1—psoriasis	1.16e-05	0.000235	CbGpPWpGaD
Vinblastine—JUN—Immune System—NFKBIA—psoriasis	1.15e-05	0.000233	CbGpPWpGaD
Vinblastine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—psoriasis	1.09e-05	0.00022	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—SOCS1—psoriasis	1.08e-05	0.000219	CbGpPWpGaD
Vinblastine—ABCB11—Metabolism—APOE—psoriasis	1.05e-05	0.000212	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism—CAT—psoriasis	1.02e-05	0.000205	CbGpPWpGaD
Vinblastine—ABCC1—Disease—HLA-A—psoriasis	1.01e-05	0.000204	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—CYP2S1—psoriasis	9.92e-06	0.0002	CbGpPWpGaD
Vinblastine—JUN—Immune System—TYK2—psoriasis	9.44e-06	0.000191	CbGpPWpGaD
Vinblastine—ABCC1—Disease—APOE—psoriasis	9.43e-06	0.00019	CbGpPWpGaD
Vinblastine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—psoriasis	9.35e-06	0.000189	CbGpPWpGaD
Vinblastine—ABCB11—Metabolism—PPARG—psoriasis	9.16e-06	0.000185	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—CAT—psoriasis	8.85e-06	0.000179	CbGpPWpGaD
Vinblastine—JUN—Immune System—IFNG—psoriasis	8.84e-06	0.000179	CbGpPWpGaD
Vinblastine—ABCC1—Disease—NOS2—psoriasis	8.79e-06	0.000177	CbGpPWpGaD
Vinblastine—JUN—Immune System—CD4—psoriasis	8.54e-06	0.000172	CbGpPWpGaD
Vinblastine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—psoriasis	8.24e-06	0.000166	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—APOE—psoriasis	8e-06	0.000162	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—LEP—psoriasis	8e-06	0.000162	CbGpPWpGaD
Vinblastine—JUN—Innate Immune System—IL6—psoriasis	7.93e-06	0.00016	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism—APOE—psoriasis	7.9e-06	0.00016	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—CARM1—psoriasis	7.86e-06	0.000159	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—NFKBIA—psoriasis	7.45e-06	0.000151	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—CARM1—psoriasis	7.41e-06	0.00015	CbGpPWpGaD
Vinblastine—JUN—Immune System—NFKB1—psoriasis	7.36e-06	0.000149	CbGpPWpGaD
Vinblastine—ABCC1—Disease—TYK2—psoriasis	7.2e-06	0.000145	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism—PPARG—psoriasis	6.88e-06	0.000139	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—APOE—psoriasis	6.88e-06	0.000139	CbGpPWpGaD
Vinblastine—JUN—Immune System—STAT3—psoriasis	6.61e-06	0.000134	CbGpPWpGaD
Vinblastine—ABCC1—Disease—CD4—psoriasis	6.51e-06	0.000131	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—TYK2—psoriasis	6.11e-06	0.000123	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—PPARG—psoriasis	5.99e-06	0.000121	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—CXCL8—psoriasis	5.32e-06	0.000107	CbGpPWpGaD
Vinblastine—ABCC1—Disease—STAT3—psoriasis	5.04e-06	0.000102	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—CARM1—psoriasis	4.84e-06	9.78e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—CAT—psoriasis	4.84e-06	9.77e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—NFKB1—psoriasis	4.76e-06	9.61e-05	CbGpPWpGaD
Vinblastine—JUN—Immune System—IL6—psoriasis	4.62e-06	9.33e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—CAT—psoriasis	4.56e-06	9.2e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—VEGFA—psoriasis	4.32e-06	8.72e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—STAT3—psoriasis	4.27e-06	8.63e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—APOE—psoriasis	3.76e-06	7.59e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—APOE—psoriasis	3.54e-06	7.15e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—IL6—psoriasis	3.52e-06	7.11e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—PPARG—psoriasis	3.27e-06	6.61e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—TP53—psoriasis	3.26e-06	6.59e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—PPARG—psoriasis	3.08e-06	6.23e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—IL6—psoriasis	2.99e-06	6.03e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—CAT—psoriasis	2.98e-06	6.02e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—APOE—psoriasis	2.32e-06	4.68e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—PPARG—psoriasis	2.02e-06	4.07e-05	CbGpPWpGaD
